Thymosin Alpha-1 (Tα1) overview:
------
Type: Endogenous thymic peptide; immune-modulating 28–amino-acid fragment derived from prothymosin α.
Sequence:
Ac–Ser-Asp-Ala-Ala-Val-Asp-Thr-Ser-Ser-Glu-Ile-Thr-Thr-Lys-Asp-Leu-Lys-Glu-Lys-Lys-Glu-Val-Val-Glu-Glu-Ala-Glu-Asn–NH₂
Molecular weight: ~3.1 kDa
Main functions:
Immunomodulatory. Enhances T-cell differentiation and function, boosts cytokine production (IL-2, IFN-γ).
Antiviral & anticancer activity: Shown in studies to enhance immune response against viral infections and tumor cells.
Adjunct in immune therapy: Studied in combination with vaccines, interferons, and chemotherapy for immune support.
Synergy potential: When paired with regenerative or anti-inflammatory peptides (e.g., BPC-157, KPV), may support immune balance and tissue recovery post-injury or during systemic inflammation.
---------
This peptide is for research purposes ONLY. It is not approved for human consumption or medical use.
All handling and usage must comply with applicable regulations and guidelines for laboratory research.
By purchasing this product you agree to the condition of its handling by qualified laboratory professionals only.
------
Additional information:
The product (substance) isn’t a food or diet supplement.
Keep out of children’s reach.
Keep container tightly closed.
Store below 8 °C; protect from moisture.
Store only in the original container.
Avoid contact during pregnancy and breastfeeding.
Consult a doctor in the event of feeling unwell or having adverse effects related to contact with the substance.